Perhaps combining this therapeutic approach with the development of small molecule agonists to TrkA to facilitate prosurvival signaling (Jang et al., 2007) or small molecule antagonists to p75NTR for anti-apoptotic actions should be added to the treatment toolbox for MCI and AD. The gene discussed is NTRK1; the disease is Alzheimer disease.